Hongwei Cheng

Prof. Dr. Hongwei Cheng

Xiamen University
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2022 in Nano-Micro Letters
Verified
Journal Article
Open access
PDF file
SBShuang Bai
Shuang Bai
YLYulu Lan
Yulu Lan
SFShiying Fu
Shiying Fu
Hongwei ChengHongwei Cheng
Hongwei Cheng
ZLZhixiang Lu
Zhixiang Lu
Gang LiuGang Liu
Gang Liu
As the indispensable second cellular messenger, calcium signaling is involved in the regulation of almost all physiological processes by activating specific target proteins. The importance of calcium ions (Ca2+) makes its “Janus nature” strictly regulated by its concentration. Abnormal regulation of calcium signals may cause some diseases; however, artificial regulation of calcium homeostasis in local lesions may also play a therapeutic role. “Calcium overload,” for example, is characterized by excessive enrichment of intracellular Ca2+, which irreversibly switches calcium signaling from “positive regulation” to “reverse destruction,” leading to cell death. However, this undesirable death could be defined as “calcicoptosis” to offer a novel approach for cancer treatment. Indeed, Ca2+ is involved in various cancer diagnostic and therapeutic events, including calcium overload-induced calcium homeostasis disorder, calcium channels dysregulation, mitochondrial dysfunction, calcium-associated immunoregulation, cell/vascular/tumor calcification, and calcification-mediated CT imaging. In parallel, the development of multifunctional calcium-based nanomaterials (e.g., calcium phosphate, calcium carbonate, calcium peroxide, and hydroxyapatite) is becoming abundantly available. This review will highlight the latest insights of the calcium-based nanomaterials, explain their application, and provide novel perspective. Identifying and characterizing new patterns of calcium-dependent signaling and exploiting the disease element linkage offer additional translational opportunities for cancer theranostics.

1 January 2019 in Theranostics
Verified
Journal Article
Open access
CCChengchao Chu
Chengchao Chu
MSMin Su
Min Su
JZJing Zhu
Jing Zhu
DLDongsheng Li
Dongsheng Li
Hongwei ChengHongwei Cheng
Hongwei Cheng
Gang LiuGang Liu
Gang Liu
Cancer treatment using functional proteins, DNA/RNA, or complex bio-entities is important in both preclinical and clinical studies. With the help of nano-delivery systems, these biomacromolecules can enrich cancer tissues to match the clinical requirements. Biomineralization via a self-assembly process has been widely applied to provide biomacromolecules exoskeletal-like protection for immune shielding and preservation of bioactivity. Advanced metal-organic framework nanoparticles (MOFs) are excellent supporting matrices due to the low toxicity of polycarboxylic acids and metals, high encapsulation efficiency, and moderate synthetic conditions. In this review, we study MOFs-based biomineralization for cancer treatment and summarize the unique properties of MOF hybrids. We also evaluate the outlook of potential cancer treatment applications for MOFs-based biomineralization. This strategy likely opens new research orientations for cancer theranostics.

1 February 2018 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
Hongwei ChengHongwei Cheng
Hongwei Cheng
ZWZhixian Wu
Zhixian Wu
CWCaisheng Wu
Caisheng Wu
XWXiaoyuan Wang
Xiaoyuan Wang
SLSing Shy Liow
Sing Shy Liow
Yun-Long WuYun-Long Wu
Yun-Long Wu

10 November 2021 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
Hongwei ChengHongwei Cheng
Hongwei Cheng
XFXiaoshan Fan
Xiaoshan Fan
EYEnyi Ye
Enyi Ye
HCHu Chen
Hu Chen
JYJing Yang
Jing Yang
Zibiao LiZibiao Li
Zibiao Li

22 December 2023 in Chinese Chemical Letters
Verified
Journal Article
Closed access
XLXiaoliu Liang
Xiaoliu Liang
CHChunliu Huang
Chunliu Huang
HLHui Liu
Hui Liu
HCHu Chen
Hu Chen
JSJiabao Shou
Jiabao Shou
Gang LiuGang Liu
Gang Liu

1 July 2020 in Journal of Controlled Release
Verified
Journal Article
Closed access
HCHu Chen
Hu Chen
Hongwei ChengHongwei Cheng
Hongwei Cheng
QDQixuan Dai
Qixuan Dai
YCYi Cheng
Yi Cheng
YZYang Zhang
Yang Zhang
Gang LiuGang Liu
Gang Liu